drugset / Trial / NCT02060487

Effects of Oral Sildenafil on Mortality in Adults With PAH

NCT02060487

Phase 4 Terminated 385 enrolled Viatris Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a blinded study in adult patients with PAH evaluating the relative effects of sildenafil on mortality when administered at the three doses (80 mg, 20 mg or 5 mg, all three times per day \[TID\]). In addition, the relative effects on clinical worsening and 6-minute walking distance (6MWD) will be assessed.

Timeline

Start
2014-09-22
Primary completion
2021-02-26
Completion
2021-02-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 5 mg Oral
Subject Sildenafil Unknown 20 mg Oral
Subject Sildenafil Unknown 80 mg Oral